Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 5
1982 6
1983 2
1984 1
1985 2
1986 2
1987 7
1988 3
1989 5
1990 6
1991 6
1992 4
1993 8
1994 2
1995 1
1996 1
1997 1
2000 1
2002 1
2003 2
2004 1
2005 4
2006 2
2007 13
2008 11
2009 19
2010 16
2011 14
2012 18
2013 10
2014 19
2015 22
2016 27
2017 11
2018 14
2019 9
2020 5
2021 2
2022 1
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, De Giorgi U, Young Joung J, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Di Santo N, Zohren F, Fizazi K. Agarwal N, et al. Among authors: szczylik c. Lancet. 2023 Jul 22;402(10398):291-303. doi: 10.1016/S0140-6736(23)01055-3. Epub 2023 Jun 4. Lancet. 2023. PMID: 37285865 Clinical Trial.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators. Rini BI, et al. Among authors: szczylik c. N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779529 Clinical Trial.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. Among authors: szczylik c. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA. Motzer RJ, et al. Among authors: szczylik c. N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Free article. Clinical Trial.
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Rini BI, et al. Among authors: szczylik c. Lancet. 2011 Dec 3;378(9807):1931-9. doi: 10.1016/S0140-6736(11)61613-9. Epub 2011 Nov 4. Lancet. 2011. PMID: 22056247 Clinical Trial.
Mechanisms of angiogenesis in neoplasia.
Sobocińska AA, Czarnecka AM, Szczylik C. Sobocińska AA, et al. Among authors: szczylik c. Postepy Hig Med Dosw (Online). 2016 Dec 8;70(0):1166-1181. Postepy Hig Med Dosw (Online). 2016. PMID: 28026820 Free article. Review.
[Cancer stem cells in renal carcinoma].
Szymanski Ł, Helbrecht I, Fiedorowicz M, Matak D, Bartnik E, Golik P, Szczylik C, Czarnecka AM. Szymanski Ł, et al. Among authors: szczylik c. Postepy Biochem. 2019 Jun 6;65(2):95-102. doi: 10.18388/pb.2019_250. Postepy Biochem. 2019. PMID: 31642647 Free article. Review. Polish.
Thyroid Hormones as Renal Cell Cancer Regulators.
Szymański Ł, Matak D, Bartnik E, Szczylik C, Czarnecka AM. Szymański Ł, et al. Among authors: szczylik c. J Signal Transduct. 2016;2016:1362407. doi: 10.1155/2016/1362407. Epub 2016 Mar 13. J Signal Transduct. 2016. PMID: 27034829 Free PMC article. Review.
Ovarian cancer as a genetic disease.
Lech A, Daneva T, Pashova S, Gagov H, Crayton R, Kukwa W, Czarnecka AM, Szczylik C. Lech A, et al. Among authors: szczylik c. Front Biosci (Landmark Ed). 2013 Jan 1;18(2):543-63. doi: 10.2741/4119. Front Biosci (Landmark Ed). 2013. PMID: 23276941 Free article. Review.
Immune consequences of anti-angiogenic therapyin renal cell carcinoma.
Brodaczewska KK, Szczylik C, Kieda C. Brodaczewska KK, et al. Among authors: szczylik c. Contemp Oncol (Pozn). 2018 Mar;22(1A):14-22. doi: 10.5114/wo.2018.73878. Epub 2018 Mar 5. Contemp Oncol (Pozn). 2018. PMID: 29628789 Free PMC article. Review.
265 results